My view on what the next six quarters may look until we hit the...

My view on what the next six quarters may look until we hit the break even target in Q4 CY 2018.

Have assumed linear growth of ADAPT revenue as I don't have sufficient detail to phase it any differently.

As you can see I believe we need between $11 and $12M in quarterly revenue to break even.

As expected the losses quickly reduce as ADAPT becomes a bigger and bigger piece of the pie.  

	Column 1	Column 2	Column 3	Column 4	Column 5	Column 6	Column 7	Column 8
0		CY2017	CY2017	CY2018	CY2018	CY2018	CY2018	Assumptions
1	Revenue ($M)[/B]	Q3	Q4	Q1	Q2	Q3	Q4
2	Infusion	3.5	3.5	3.5	3.5	3.5	3.5	$14M annual
3	ADAPT	3	4	5	6	7	8
4
5	Total Revenue	6.5	7.5	8.5	9.5	10.5	11.5
6
7	Margin
8	Infusion	1.8	1.8	1.8	1.8	1.8	1.8	50%
9	ADAPT	2.1	2.8	3.5	4.2	4.9	5.6	70%
10
11	Total Margin	3.9	4.6	5.3	6.0	6.7	7.4
12
13	SG&A	6.8	6.8	6.8	6.8	6.8	6.8	$27M annual spend
14
15	Profit/(loss)	(2.9)	(2.2)	(1.5)	(0.8)	(0.1)	0.6

Obviously just my opinion DYOR